Azathioprine therapy in polymyositis.
D000328:Adult; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000627:therapeutic use*; D002648:Child; D003402:Creatine Kinase / Q000032:analysis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D008297:Male; D009132:Muscles / Q000201:enzymology; D009220:Myositis / Q000188:drug therapy* / Q000201:enzymology; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D011278:Pregnanes / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors
D007166:Immunosuppressive Agents; D011278:Pregnanes; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase; D001379:Azathioprine; D011241:Prednisone